AIDS Research Today is a free monthly online journal that collates and summarizes the latest research about AIDS, including details on testing, treatment, prevention, hiv, life expectancy.

Volume 3 (2006), Issue 6 (June)

1. A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.
   J Infect Dis, 194(1): 20-8. [Abstract] [Full-text]
2. The survival benefits of AIDS treatment in the United States.
   J Infect Dis, 194(1): 11-9. [Abstract] [Full-text]
3. HIV-1 Tat depresses DNA-PK(CS) expression and DNA repair, and sensitizes cells to ionizing radiation.
   Int J Radiat Oncol Biol Phys, 65(3): 842-50. [Abstract] [Full-text]
4. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy.
   Clin Microbiol Infect, 12(7): 666-71. [Abstract] [Full-text]
5. Reform of drug control policy for palliative care in Romania.
   Lancet, 367(9528): 2110-7. [Abstract] [Full-text]
6. Multisectoral responses to HIV/AIDS: applying research to policy and practice.
   Am J Public Health, 96(7): 1189-91. [Abstract] [Full-text]

© 2004-2008 AIDS Research Today. All Rights Reserved.